Press Releases

New vaccine being studied for HPV-positive head and neck cancers
Researchers at Providence Cancer Institute are exploring a range of innovative approaches to targeting human papillomavirus-positive head and neck squamous cell cancer.
Providence joins Rome Call for AI Ethics
Providence becomes first health system to join international endorsement of ethical use of AI.
Providence Spins Out Praia Health with $20M in Oversubscribed Series A Funding
Following Providence’s successful implementation, Community Health Network becomes Praia Health's first external customer. Praia Health welcomes sixteen health organizations to the ecosystem.
Facilitating easier access for providers and health systems, MedPearl to be added to Microsoft Teams and Azure Marketplace
Providence’s EMR-integrated education and referral platform provides specialist expertise to front-line clinicians at the point of care.
Providence reports year-end 2023 results
The not-for-profit health system made significant progress in the face of ongoing challenges and invested nearly $2.1 billion in community benefit.
Providence names Susan Huang, M.D., chief executive for Providence Clinical Network
Former chief medical officer of Providence South Division will lead the not-for-profit health system's ambulatory operations as the new chief executive, effective Feb. 26, 2024.
Dose-escalation studies aspire to fill gaps in cancer treatment options
Two early phase trials available at Providence Cancer Institute to evaluate escalating doses of different potential cancer treatments in patients with advanced solid tumors.
Providence study finds new workflow improves adherence to Infant Group B Strep Sepsis prevention guidelines
A recent Providence study revealed that integrating a dynamic EMR order set results in improved adherence to established guidelines associated with reduction in early onset GBS neonatal sepsis.
10 health care trends to watch in the year ahead
Providence CEO Rod Hochman, M.D., releases his sixth-annual list of predictions, calling 2024 the year of health care transformation through collaboration.
Providence reports Q3 2023 results
The not-for-profit health system continued to serve more people while staying the course on strategies for recovery and renewal.
Immunotherapies for GI and lung cancers evaluated in new studies
A study for people with GI cancers and two studies for people with advanced and early-stage lung cancer hope to develop better treatment options with the help of immunotherapy.
Providence becomes first major health system to implement HL7® Da Vinci Project’s “Clinical Data Exchange” standards
The HL7 FHIR® standard makes clinical and administrative data available in a standardized and secure format to help reduce inefficiencies and increase quality of care.